Masimo (NASDAQ:MASI) today announced that Cambridge University Hospitals NHS Foundation Trust, U.K. is adopting the Masimo W1 advanced health tracking watch for use in its telehealth and telemedicine programs. Masimo W1, which offers accurate, continuous measurements of key physiological parameters, is available in the UK as a medical device that integrates with the Masimo SafetyNet remote patient management platform.
Here’s How Much You Would Have Made Owning Amgen Stock In The Last 15 Years
Amgen (NASDAQ:AMGN) has outperformed the market over the past 15 years by 4.34% on an annualized basis producing…
